Appointment Bolsters MTS' Global Life Sciences
Practice
NEW
YORK, June 17, 2024 /PRNewswire/ -- MTS
Health Partners welcomes Evan Matlin
as a Partner in the Life Sciences Group. Matlin's appointment marks
a significant addition to the Firm's global life sciences practice,
which secured the second-highest total M&A deal value in the
biotech industry with $50+ billion in 2023. His experience in this
sector, as well as the tools and diagnostics sector, adds a dynamic
new element to the Firm's advisory coverage.
With a distinguished career spanning over 18 years, Matlin
brings a wealth of practical knowledge to MTS Health Partners.
Prior to joining MTS, and during his tenure at Barclays, Matlin was
Co-Head of Healthcare M&A and spearheaded healthcare M&A
efforts for the EMEA regions, playing a pivotal role in shaping the
industry landscape. Over the course of his career, he has handled
more than 50 completed transactions valued at over $225 billion.
Curtis Lane, Founding Partner of
MTS Health Partners, expressed his excitement about Matlin joining
the team, stating, "Evan's proven track record and deep
understanding of the healthcare sector make him a valuable asset to
MTS. His global perspective will further enhance our ability to
deliver strategic solutions to our clients."
MTS Managing Partner Andrew
Weisenfeld added, "Evan's appointment underscores our
commitment to providing world-class advisory services to clients.
His expertise will bolster our Life Sciences Group and strengthen
our position as a leader in healthcare investment banking."
"I am thrilled to be part of such a dynamic, fast-growing and
forward-thinking team. I look forward to leveraging my experience
to support the Firm's life sciences practice and contribute to its
continued success," said Matlin.
Prior to joining MTS Health Partners, Matlin held prominent
roles at Barclays, and served on the Healthcare teams at Deutsche
Bank, Lazard, and CIBC World Markets. He graduated from The
George Washington University in 2005
with a BA in Economics.
About MTS
MTS Health Partners is the largest independent healthcare-dedicated
investment bank, with more than 85 professionals and nearly
$65 billion worth of transactions
completed since 2020. For over 20 years, MTS has continued to
foster trusted client partnerships, creating alignment to achieve
our strategic goals. We provide our clients with creative thinking,
candid advice, and a commitment to results, advising them in
pursuing the right strategic pathways, rather than simply focusing
on transactions. Through close client partnerships based on trust
and shared goals, we are at your side and on your side, every step
of the way.
Securities related transactions are provided exclusively by our
affiliate, MTS Securities, LLC, a broker-dealer registered with the
SEC and a member of FINRA and SIPC.
For more information about MTS Health Partners, please visit
www.mtspartners.com.
Contact
Andrew Scott
Director of Marketing & Communications
MTS Health Partners
Phone: (646) 975-6583
Email: scott@mtspartners.com
Website: www.mtspartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/evan-matlin-joins-mts-health-partners-as-partner-in-life-sciences-group-302173682.html
SOURCE MTS Health Partners